iPSC-Derived Natural Killer (NK) Cells with Media

Cat.-Nr.: ASE-9285

Description

Take advantage of 25% off on these iPSC-derived Cells with Media – offer ends December 31, 2025

Applied StemCell has developed an efficient integration-free, small molecule-based method to differentiate high-quality natural killer (NK) cells from human iPSCs at passage 0 (P0). The differentiated NK cells recapitulate the phenotype and functional parameters of primary and in vivo NK cells.

We provide NK cells differentiated from an integration-free, control human iPSC line (#ASE-9211), reprogrammed from fibroblasts of an African American male donor. These cryopreserved, high-purity (>80%) cells express high levels of NK biomarkers CD56 and CD45.

These iPSC-differentiated NK cells can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived NK cells for drug screening applications. These NK cells can also be used as effector cells in cytotoxicity assays.

These iPSC-derived cells are available from the following donors:
– Normal, Male, African American, Neonate, from Fibroblasts (#ASE-9211)

– Normal, Male, Hispanic, from CD34+ Umbilical Cord Blood Cells (#ASE-9250)

Please contact us for more information.

 

  • SUPPLIER:

    Applied StemCell

  • STATUS:

    In Stock

  • SIZE:

    1.000.000 cells/vial

Overview

iPSC-Derived Natural Killer (NK) Cells with Media
  • Species: Human
  • Keywords: iPSC-derived cells
  • iPSC: iPSC-Derived Natural Killer Cells
  • Features: cryopreserved, male
  • Cell Type: Hematopoietic cells
  • Features:kit - iPSC-derived Nk cells, NK Cell Culture Media, NK Cell Media Supplement A (100x)

RELATED PRODUCTS


Skeletal Muscle Differentiation Service from iPSCiPSC Disease Modeling – Toxicology Testing